Cell Therapy News Volume 27.15 | Aug 31 2026

    0
    24







    2026-08-31 | CTN 27.15


    Cell Therapy News by STEMCELL Technologies
    Vol. 27.15 – 31 August, 2026
    TOP STORY

    CD19 CAR T Cell Therapy for Treatment-Refractory Seropositive Rheumatoid Arthritis: A Phase I Trial

    Scientists reported clinical and molecular data obtained during the nonrandomized Phase I part of the Phase I/II COMPARE trial, evaluating safety and efficacy of mivocabtagene autoleucel (miv-cel), an autologous fully human CD19 CAR T cell therapy, in rheumatoid arthritis.
    [Nature Medicine]

    Abstract
    SepMateâ„¢ PBMC Isolation
    PUBLICATIONSListed by the impact factor of the journal

    Expansion and CAR Engineering of Granulocyte-Monocyte Progenitors for Cellular Immunotherapy

    Researchers developed defined culture conditions that enable long-term expansion of mouse and human granulocyte-monocyte progenitors (GMPs) while preserving progenitor identity and myeloid potential, establishing GMPs as a renewable engineering platform.
    [Cell]

    Full Article | Graphical Abstract

    T Cell Immunosenescence Limits CD19 CAR T Cell Function in Chronic Lymphocytic Leukemia

    Investigators identified immunosenescence as a measurable and functionally consequential barrier to CAR T cell efficacy in chronic lymphocytic leukemia and a candidate for therapeutic modulation.
    [Blood]

    Abstract

    Targeting Regnase-1 in B7-H3-CAR T Cells Reprograms the Tumor Microenvironment and Enhances Antitumor Efficacy for Osteosarcoma

    Scientists evaluated the intrinsic and extrinsic effects of deleting the negative regulator Regnase-1 in B7-H3-CAR T cells for the immunotherapy of osteosarcoma.
    [Cell Reports Medicine]

    Full Article | Graphical Abstract

    C-Terminus CD28 Phosphorylation, Y218, Modulates IL-2 Secretion, and Therapeutic Effect of CAR-T Cells

    The authors identified tyrosine 218 (Y218) in the CD28 cytoplasmic domain as a critical regulatory site, and demonstrated that its phosphorylation is essential for optimal CAR-T cell activity.
    [Molecular Therapy]

    Abstract | Graphical Abstract

    Tisa-Cel and Axi-Cel CAR Structure Influences the Development of Resistance to CD19-CAR-T Therapy

    Researchers showed that CAR structure is a critical determinant of CD19 loss in tumor B cells. Specifically, repeated exposure to CD19–4-1BB-based CAR-T cells, but not CD19–CD28-based counterparts, drives FMC63-epitope and total CD19 protein loss.
    [Leukemia]

    Full Article
    Keep current with the latest in cancer stem cell research
    REVIEWS

    Ex Vivo Live Macrophage Engineering Strategies in Immunotherapy

    Successful macrophage immunotherapy requires solving two central in vivo determinants: preserving a therapeutically favorable functional state despite suppressive cues, and achieving robust, disease-selective localization and engagement.
    [Biotechnology Advances]

    Abstract
    INDUSTRY AND POLICY NEWS

    OHSU Researcher Awarded $4.2 Million to Advance Stem Cell Therapy for Age-Related Macular Degeneration

    Dr. Trevor McGill at Oregon Health & Science University (OHSU) has received a major federal grant to develop a new generation of stem cell therapies that could one day help preserve sight for those with the disease without requiring long-term immune-suppressing drugs.
    [OHSU]

    Abstract
    FEATURED EVENT

    SLB 2026

    September 14-17, 2026
    Columbus, Ohio, United States

    > See All Events

    JOB OPPORTUNITIES

    Quality Control Specialist – Cell Therapies

    University of British Columbia – Vancouver, British Columbia, Canada

    R&D Specialist – Gene Editing and Gene Translation Metabolism

    University of Luxembourg – Luxembourg

    Chair – Regenerative Medicine and Cell Biology

    MUSC College of Medicine – Charleston, South Carolina, United States

    Postdoctoral Associate – Lung Cancer

    Yale School of Medicine – New Haven, Connecticut, United States

    Research Technologist – Pediatric Rhabdomyosarcoma Pathobiology

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2


    1618 Station Street

    Vancouver, BC, V6A 1B6, Canada

    Unsubscribe or manage your subscriptions here.

    View the Science News privacy policy here.